Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Mathematical modeling of viral kinetics:

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Diagnosis of irritable bowel syndrome

Leptin, obesity, and liver disease

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Huge Adrenal Hemangioma: A Rare Cause of Deceivingly High Liver Stiffness Measurement by Transient Elastography Grace Lai-Hung Wong, Raymond Kwok, Vincent.

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Psychiatric disorders among veterans with hepatitis C infection

Volume 124, Issue 4, Pages (April 2003)

PPI-based triple therapy in the eradication of H. pylori infection

Spreading and focusing of gluten epitopes in celiac disease

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Hepatitis B infection in heart transplant recipients

Appendectomy is followed by increased risk of Crohn's disease

Short-Bowel Syndrome Clinical Gastroenterology and Hepatology

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Chi–Jen Chu, Munira Hussain,

Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH

Volume 120, Issue 3, Pages (February 2001)

Yasuhiko Sugawara, Masatoshi Makuuchi

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Abstracts from Around the World

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Acute hepatitis C: Current status and remaining challenges

Incidence of Statin Hepatotoxicity in Patients With Hepatitis C

Volume 120, Issue 4, Pages (March 2001)

Michael Charlton Clinical Gastroenterology and Hepatology

Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.

Leon P. McLean, Jonathan S. Chun, Raymond K. Cross

Severe Constipation Clinical Gastroenterology and Hepatology

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Brennan M.R. Spiegel, Nimish B. Vakil, Joshua J. Ofman

Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis Karin L. Andersson, Joshua A. Salomon,

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Psychiatric disorders among veterans with hepatitis C infection

Image of the month Gastroenterology

HCV targeting of patients with cirrhosis

Issue Highlights Clinical Gastroenterology and Hepatology

Chronic Diarrhea Clinical Gastroenterology and Hepatology

AGA technical review on osteoporosis in gastrointestinal diseases

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs George F. Longstreth, Douglas A. Drossman

Volume 122, Issue 4, Pages (April 2002)

Reply to: “Flow cytometry makes all the difference”

Michelle Maria Pietzak Gastroenterology

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

Cytomegalovirus Infection in a Liver Transplant Patient Identified by Endoscopically Severe Duodenal Papillitis Georgios I. Papachristou, Thomas C. Smyrk,

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease Lauren B. Gerson, Peter W. Groeneveld,

Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Kathleen E. Corey, Andrew S

Hepatic oxygen supplementation as therapy in cirrhotic liver disease

Predictors of response to infliximab in patients with Crohn's disease

Medical Therapy for Refractory Pediatric Crohn’s Disease

Volume 120, Issue 4, Pages (March 2001)

Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease Lauren B. Gerson, Peter W. Groeneveld,

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato Gastroenterology Volume 124, Issue 4, Pages 1166-1167 (April 2003) DOI: 10.1053/gast.2003.50200 Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 1 Sensitivity analysis on SVR rate for the patient with HCV-1b (F3) and transition probability of liver diseases for NR patients. Two-way sensitivity analysis in the case of severe HCV-1b infection (HCV-1b[F3]) (40 years old). Strategy 5 is treat-all strategy (see Moriguchi et al. Hepatology 2002). Gastroenterology 2003 124, 1166-1167DOI: (10.1053/gast.2003.50200) Copyright © 2003 American Gastroenterological Association Terms and Conditions